期刊文献+

厄贝沙坦对5/6肾切除及腹主动脉缩窄大鼠左心室肥厚及心肌尿素转运蛋白B表达的影响 被引量:3

Effects of irbesartan on left ventricular hypertrophy and expression of urea transporter B in myocardium of 5/6 nephrectomized rats with constricted abdominal aorta
下载PDF
导出
摘要 目的观察血管紧张素Ⅱ受体拮抗剂厄贝沙坦对5/6肾切除及腹主动脉缩窄大鼠左心室肥厚及心肌尿素转运蛋白B(UT-B)表达的影响。方法 SD大鼠随机分为假手术组、5/6肾切除组(肾衰组)、腹主动脉缩窄组(心衰组)、肾衰+心衰组及相应的厄贝沙坦干预组,每组8只。分组处理后,测定各组大鼠血清肌酐(SCr)、血尿素氮(BUN)、血管紧张素Ⅱ(AngⅡ)、B型利钠肽(BNP);取大鼠心脏,测定左心室质量与全心质量的比值(LVW/HW)、全心质量与体质量的比值(HW/BW)、左心室质量与体质量的比值(LVW/BW);RT-PCR和Western blotting检测心肌UT-B表达。结果与假手术组比较,肾衰组、心衰组及肾衰+心衰组大鼠出现心肌肥厚,LVW/HW、HW/BW、LVW/BW增大,血清AngⅡ和BNP水平增高,心肌组织UT-B mRNA和UT-B蛋白表达上调;肾衰组和肾衰+心衰组SCr、BUN水平升高。与肾衰组、心衰组及肾衰+心衰组比较,相应的厄贝沙坦干预组大鼠的心肌肥厚明显减轻,LVW/HW、HW/BW、LVW/BW降低,血清AngⅡ和BNP下降,心肌UT-B mRNA和UT-B蛋白表达下调。与肾衰组和肾衰+心衰组比较,相应的厄贝沙坦干预组大鼠SCr、BUN水平降低。结论 5/6肾切除及腹主动脉缩窄均可引起大鼠心功能明显下降,出现左心室肥厚,同时心肌UT-B表达增加;厄贝沙坦在改善心、肾功能的同时抑制心肌UT-B表达,UT-B可能在肾功能不全合并心力衰竭的发生中具有重要作用。 Objective To observe the effects of angiotensin Ⅱ receptor antagonist irbesartan on left ventricular hypertrophy and the expression of urea transporter B(UT-B) in myocardium of 5/6 nephrectomized rats with constricted abdominal aorta.Methods SD rats were randomly divided into the sham group,5/6 nephrectomy group,abdominal aorta constriction group,5/6 nephrectomy and abdominal aorta constriction group,and irbesartan group.Each group consisted of eight rats.Serum Cr,BUN,Ang Ⅱ,and BNP were detected after rats were sacrificed.Rat hearts were harvested and the left ventricular weight/heart weight(LVW /HW),heart weight/body weight(HW/BW),and left ventricular weight/body weight(LVW/BW) were measured.The expression of UT-B in myocardium was determined by RT-PCR and Western blotting.Results Compared with the sham group,rats of 5/6 nephrectomy group,abdominal aorta constriction group,and 5/6 nephrectomy and abdominal aorta constriction group had the left ventricular hypertrophy and elevated LVW /HW,HW /BW,LVW /BW,serum Ang Ⅱ,BNP,and mRNA and protein expressions of UT-B in myocardium.Levels of SCr and BUN of the 5/6 nephrectomy group and 5/6 nephrectomy and abdominal aorta constriction group increased.Compared with above three groups,rats of the irbesartan group had alleviated left ventricular hypertrophy and lower LVW/HW,HW/BW,LVW/BW,serum Ang Ⅱ,BNP,and mRNA and protein expressions of UT-B in myocardium.Compared with the 5/6 nephrectomy group and 5/6 nephrectomy and abdominal aorta constriction group,levels of SCr and BUN of the irbesartan group were lower.Conclusion5/6 nephrectomy and abdominal aorta constriction can cause significant decrease of heart function of rats,left ventricular hypertrophy,and elevated expression of UT-B.Irbesartan can improve heart and kidney functions and inhibit the expression of UT-B,which may play an important role in heart failure of rats with renal inadequacy.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2016年第2期189-194,共6页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市卫生局资助项目(2010102)~~
关键词 厄贝沙坦 尿素转运蛋白B 5/6肾切除 腹主动脉缩窄 大鼠 irbesartan urea transporter 5/6 nephrectomy constriction of the abdominal aorta rat
  • 相关文献

参考文献15

  • 1Coresh J, Selvin E, Stevebs LA, et al. Prevalence of chronie kidney disease in the United States[J]. JAMA, 2007, 298 (17): 2038- 2047.
  • 2张路霞,左力,徐国宾,王芳,王淑玉,王梅,吕继成,张军茹,刘力生,王海燕.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2):67-71. 被引量:369
  • 3Collcton BF, Larson MG, Wilson PW, et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insuffi- eieney[J]. Kidney lnt, 1999, 56(6): 2214 -2219.
  • 4Collins AJ, Foley RN, Gilbertson DT, et al. United States Renal Data Sys|em public health surveillance of chronic kidney disease and end-stage reualdisease[J]. Kidney Int Suppl,2015, 5(1): 2-7.
  • 5Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis [ J ]. Semin Dial, 2003, 16 (2) : 101 - 105.
  • 6Centers for disease control and prevention ( CDC ). State-specific trends in chronic kidney failure, United States, 1990 - 2001 [ J ]- MMWR Mortal Wkly Rep, 2004, 53(39) : 918 -920.
  • 7Doran JJ, Klein JD, Kim YH, et al. Tissue distribution of UT-A and UT-B mRNA and protein in rat[J]. Am J Physiol Regul lntegr Comp Physiol, 2006, 290(5): R1446- R1459.
  • 8Hill WG. Southern NM. Maelver B. et al. Isolation and characte- rization of the Xenopus oocyte plasma membrane: a new method for studying activity of water and solute transporters[ J] Am J Physiol Renal Physiol, 2005, 289( 1 ) : F217 -F224.
  • 9Maciver B, Smith CP, Hill WG, et al. Functional characterization of mouse urea transporters UT-A2 and UT-A3 expressed in purified Xenopus laevis ooeyte plasma membranes [ J]. Am J Physiol Renal Physiol, 2008, 294(4) : F956 - F964.
  • 10Zhao D, Sonawane ND, Levin MH, et al. Comparative transport effieiencies of urea analogues through urea transporter UT-B [ J ] Biochim Biophys Aeta, 2007, 1768(7) : 1815 -21.

二级参考文献25

  • 1张木兰,李颖军,孙英贤,侯淑贤.尿毒症性心肌病(附934例分析)[J].吉林医学,1993,14(4):212-213. 被引量:2
  • 2张路霞,王梅,王海燕.慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2005,21(7):425-428. 被引量:69
  • 3Xue JL,Ma JZ,Louis TA,et al.Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.J Am Soc Nephrol,2001,12:2753-2758.
  • 4Coresh J,Astor BC,Green T,et al.Prevalence of Chronic Kidney Disease and Decreased Kidney Function in the Adult US Population:Third National Health and Nutrition Examination Survey.Am J Kidney Dis,2003,41:1-12.
  • 5Chobanian AV,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on prevention,detection,evaluation and treatment of high blood pressure.JAMA,2003,21:2560-2572.
  • 6Anonymous.KDOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Kidney Disease Outcome Quality Initiative.Am J Kidney Dis,2002,39 Suppl 2:S1-S246.
  • 7Chadban SJ,Briganti EM,Kerr PG,et al.Prevalence of kidney damage in Australian adults:the AusDiab kidney study.J Am Soc Nephrol,2003,14:S131-S138.
  • 8Garg AX,Kiberd BA,Clark WF,et al.Albuminuria and renal insufficiency prevalence guides population screening:results form the NHANESⅢ.Kidney Int,2002,61:2165-2175.
  • 9Ramirez SP,Mcclellan W,Port FK,et al.Risk factors for proteinuria in a large,multiracial,southeast Asian population.J Am Soc Nephrol,2002,13:1907-1917.
  • 10Levey AS,Eckardt KU,Tsukamoto Y,et al.Definition and classification of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO).Kidney Int,2005,67:2089-2100.

共引文献369

同被引文献35

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部